Turning Routine Slides Into Molecular Maps
Could a standard H&E slide contain enough information to predict gene expression, methylation patterns, and even aspects of spatial biology?
-
By
-
Helen Bristow
-
July 13, 2026
-
Clinical Scorecard: Turning Routine Slides Into Molecular Maps
At a Glance
| Category | Detail |
|---|
| Condition | Precision Oncology |
| Key Mechanisms | AI platforms for inferring molecular insights from pathology slides. |
| Target Population | Pathologists, cancer clinicians, researchers, and academic institutions. |
| Care Setting | Pathology laboratories. |
Key Highlights
- AI tools can provide molecular insights faster and at lower costs compared to traditional sequencing.
- Path2Omics predicts bulk molecular information from pathology images across 30 tumor types.
- Path2Space aims to infer spatial transcriptomics from digital pathology images.
- AI-derived spatial characterization outperformed multi-omics approaches in predicting treatment response.
Guideline-Based Recommendations
Diagnosis
- Utilize AI platforms to infer molecular data from routine pathology slides.
Management
- Incorporate inferred bulk and spatial molecular insights into treatment decision-making.
Monitoring & Follow-up
- Evaluate the predictive performance of AI models against traditional methods.
Risks
- Consider the potential for information overload with detailed spatial data.
Patient & Prescribing Data
Patients undergoing cancer treatment.
AI models can help match patients to therapies based on inferred molecular data.
Clinical Best Practices
- Leverage AI tools to enhance the accessibility of molecular insights in clinical settings.
- Focus on validating AI models before clinical application.
Related Resources & Content
